From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...
A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced form of blood cancer could benefit, it is believed. The condition develops ...
Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
News Medical on MSN1d
Novel NK cell therapy shows strong response in lymphoma patientsA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
According to a 2018 review, autologous transplants are the standard treatment for young, otherwise healthy people with Hodgkin’s lymphoma if initial treatments have been ineffective. The ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
There are two types of lymphoma: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Most B-cell lymphomas are non-Hodgkin's lymphoma. B-cell lymphomas come in many types. Some grow quickly and others ...
• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback